Efficacy of two educational interventions about inhalation techniques in patients with chronic obstructive pulmonary disease (COPD). TECEPOC: Study protocol for a partially randomized controlled trial (preference trial)

Trials

Volumn 13, Issue , 2012, Pages

  Leiva Fernández, Francisca ^a   Leiva Fernández, José ^b   Zubeldia Santoyo, Fernando ^b   García Ruiz, Antonio ^c   Prados Torres, Daniel ^a   Barnestein Fonseca, Pilar ^a  

^a Family and Community Medicine Teaching Unit of Malaga   (Spain)

^b Velez Sur Health Centre   (Spain)

^c UNIVERSIDAD DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; INHALATION; INHALER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT EDUCATION; PATIENT PREFERENCE; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; ATTITUDE TO HEALTH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; EQUIPMENT DESIGN; INHALATIONAL DRUG ADMINISTRATION; METHODOLOGY; NEBULIZER; PUBLICATION; SPAIN; TASK PERFORMANCE; TREATMENT OUTCOME;

BRONCHODILATING AGENT;

ADMINISTRATION, INHALATION; BRONCHODILATOR AGENTS; EQUIPMENT DESIGN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NEBULIZERS AND VAPORIZERS; PAMPHLETS; PATIENT EDUCATION AS TOPIC; PATIENT PREFERENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESEARCH DESIGN; SPAIN; TASK PERFORMANCE AND ANALYSIS; TREATMENT OUTCOME;

EID: 84861217789     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-13-64     Document Type: Article

References (35)

1. Giner J, Basualdo LV, Casan P, Hernández C, Macián V, Martínez I, Mengíbar A. Recomendaciones SEPAR: utilización de fármacos inhalados. 2002. Arch Bronconeumol 2000, 36:34-43. Available in: www.separ.es.
2. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broedres M, Dekhuijzen R, Sanchis J, Viejo JL, Barnes P, Corrigan C, Levy M, Crompton GK. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008, 102:593-604. 10.1016/j.rmed.2007.11.003, 18083019.
3. Crompton G. A brief history of inhaled asthma therapy over the last fifty years. Prim Care Respir J 2006, 15:326-331. 10.1016/j.pcrj.2006.09.002, 17092772.
4. Pedersen S, Frost L, Arnfred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy 1986, 41:118-124. 10.1111/j.1398-9995.1986.tb00287.x, 3706674.
5. Goren A, Noviski N, Avital A. Assessment of the ability of young children to use a powder inhaler device (Turbuhaler). Pediatr Pulmonol 1994, 18:77-80. 10.1002/ppul.1950180204, 7970922.
6. Molimard M, Rahersion C, Lignot S. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med 2003, 16:249-254. 10.1089/089426803769017613, 14572322.
7. van der Palen J, Klein JJ, van Herwaarden CLA. Multiple inhalers confuse asthma patients. Eur Respir J 1999, 14:1034-1037. 10.1183/09031936.99.14510349, 10596686.
8. van der Palen J, Klein JJ, Kerkhoff AHM. Evaluation of the effectiveness of four different inhalers in patients with chronic obstructive pulmonary disease. Thorax 1995, 50:1183-1187. 10.1136/thx.50.11.1183, 475091, 8553275.
9. Crompton GK, Barnes PJ, Broeders M, Corrigan C, Corbetta L, Dekhuijzen R, , et al. Aerosol Drug Management Improvement Team The need to improve inhalation technique in Europe: a report from the aerosol drug management improvement team. Resp Med 2006, 100:1479-1494. Aerosol Drug Management Improvement Team.
10. Rau JL. Practical problems with aerosol therapy in COPD. Respir Care 2006, 51:158-172.
11. Gray SL, Williams DM, Pulliam CC, Sirgo MA, Bishop AL, Donohue JF. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med 1996, 156:984-988. 10.1001/archinte.1996.00440090084008, 8624178.
12. Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J 2002, 78:37-39. 10.1136/pmj.78.915.37, 1742227, 11796871.
13. Seeto L, Lim S. Asthma and COPD. Inhalation therapy-clarity or confusion?. Aust Fam Physician 2001, 30:557-561.
14. Melani AS. Inhalatory therapy training: a priority challenge for the physician. Acta Biomed 2007, 78:233-245.
15. Hanania NA, Wittman R, Kesten S. Medical personnel's knowledge of an ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994, 105:111-116. 10.1378/chest.105.1.111, 8275720.
16. Duerden M, Price D. Training issues in the use of inhalers. Dis Manage Health Outcomes 2001, 9:75-87.
17. De Boeck K, Alifier M, Warnier G. Is the correct use of a dry powder inhaler (Turbohaler) age dependent?. J Allergy Clin Immunol 1999, 103:763-767. 10.1016/S0091-6749(99)70417-3, 10329807.
18. Gracia-Antequera M, Morales Suarez-Varela MM. An intervention to improve the inhalatory technique of children and adolescents with asthma. Allergol Immunopathol 1999, 27:255-260.
19. Kamps AWA, Brand PLP, Roorda RJ. Determinants of correct inhalation technique in children attending a hospital-based asthma clinic. Acta Paediatr 2002, 91:159-163. 10.1111/j.1651-2227.2002.tb01688.x, 11952002.
20. Nimmo CJR, Chen DNM, Martinusen SM, Ustad TL, Ostrw DN. Assessment or patient acceptance and inhalation technique of a pressurized aerosol inhaler and two breath-actuated devices. Ann Pharmacother 1993, 27:922-927.
21. Sanchís-Aldás J, Casan-Clará P, Castillo-Gómez J, Gómez-Mangado N, Palenciano-Ballesteros L, Roca-Torrent J. Normativa SEPAR Espirometría forzada. 2011, 12:40. Available at: http://www.separ.es/publicaciones/ normativas_y_procedimientos.html. (accessed May 2010.
22. Preference Collaborative Review Group Patientś preferences within randomised trials: systematic review and patient level meta-analysis. BMJ 2008, 337:a1864. 2659956, 18977792, Preference Collaborative Review Group.
23. Brewin CR, Bradley C. Patient preferences and randomised clinical trials. BMJ 1989, 299:313-315. 10.1136/bmj.299.6694.313, 1837157, 2504416.
24. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984, 85:751-758. 10.1378/chest.85.6.751, 6723384.
25. Schilling RSF, Hughes JPW, Dingwall-Fordyce I. Disagreement between observers in an epidemiological study of respiratory disease. Br Med J 1955, 1:65-68. 10.1136/bmj.1.4905.65, 2060801, 13219343.
26. Ferrer M, Alonso J, Prieto L, Plaza V, Monso E, Marrades R, Aguar MC, Khalaf A, Antó JM. Validity and reliability of the St George's respiratory questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J 1996, 9:1160-1166. 10.1183/09031936.96.09061160, 8804932.
27. Herdman M, Badía X, Berra S. El EuroQoL-5D: una alternativa sencilla para la medición de la calidad de vida relacionada con la salud en Atención Primaria. Aten Primaria 2001, 28:425-430.
28. Peces-Barba G, Barberá JA, Agustí A, Casanova C, Casas A, Izquierdo JL, Jardim J, López Varela V, Monsó E, Montemayor T, Viejo JL. Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. Normativa SEPAR. Arch Bronconeumol 2008, 44:271-281.
29. Bellón JA, Delgado A, del Luna-Castillo J, Lardelli P. Validez y fiabilidad del cuestionario de función familiar Apgar-familiar. Aten Primaria 1996, 18:289-294.
30. Janevic MR, Janz NK, Dodge JA, Lin X, Pan W, Sinco BR, Clark NM. The role of choice in health education intervention trials: a review and case study. Social Sci Med 2003, 56:1581-1594.
31. King M, Nazareth I, Lampe F, Bower P, Chandler M, Morou M, Sibbald B, Lai R. Impact of participants and physician intervention preferences on randomised controlled trials: a systematic review. JAMA 2005, 293:1089-1099. 10.1001/jama.293.9.1089, 15741531.
32. Luque MJ. Eficacia de una intervención terapéutica multifactor sobre el exceso de peso en Atención Primaria. PhD thesis. Pharmacology Department (UMA)/Family and Community Medicine Teaching Unit from Malaga (Health District Malaga) 2006, Málaga University, Málaga, Spain.
33. Barnestein-Fonseca P, Leiva-Fernández J, Vidal-España F, García-Ruiz A, Prados-Torres D, Leiva-Fernández F. Efficacy and Safety of a multifactor intervention to improve therapeutic adherence in patients with Chronic Obstructive Pulmonary Disease (COPD): protocol for the ICEPOC Study. BMC Trials 2011, 12:40.
34. Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ 1998, 17:1185-1190.
35. Torgerson D, Sibblald B. Understanding controlled trials: what is a patient preference trial?. BMJ 1998, 316:360. 10.1136/bmj.316.7128.360, 2665528, 9487173.